229 related articles for article (PubMed ID: 22682768)
1. Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam.
Blum J; Raghavan S; Dabash R; Ngoc Nt; Chelli H; Hajri S; Conkling K; Winikoff B
Int J Gynaecol Obstet; 2012 Aug; 118(2):166-71. PubMed ID: 22682768
[TBL] [Abstract][Full Text] [Related]
2. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
Dahiya K; Mann S; Nanda S
Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
[TBL] [Abstract][Full Text] [Related]
8. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
[TBL] [Abstract][Full Text] [Related]
9. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA;
Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850
[TBL] [Abstract][Full Text] [Related]
10. Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone.
Ngoc NT; Blum J; Raghavan S; Nga NT; Dabash R; Diop A; Winikoff B
Contraception; 2011 May; 83(5):410-7. PubMed ID: 21477682
[TBL] [Abstract][Full Text] [Related]
11. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
[TBL] [Abstract][Full Text] [Related]
12. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
[TBL] [Abstract][Full Text] [Related]
13. Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
Mittal S; Agarwal S; Kumar S; Batra A
Indian J Med Res; 2005 Aug; 122(2):132-6. PubMed ID: 16177470
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion.
Chong E; Tsereteli T; Nguyen NN; Winikoff B
Contraception; 2012 Sep; 86(3):251-6. PubMed ID: 22305917
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial.
Ngoc NTN; Shochet T; Raghavan S; Blum J; Nga NTB; Minh NTH; Phan VQ; Winikoff B
Obstet Gynecol; 2011 Sep; 118(3):601-608. PubMed ID: 21860289
[TBL] [Abstract][Full Text] [Related]
18. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
[TBL] [Abstract][Full Text] [Related]
19. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
[TBL] [Abstract][Full Text] [Related]
20. Concurrent use of mifepristone and misoprostol for early medical abortion.
Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
